Literature DB >> 28356976

CD147 promotes the proliferation, invasiveness, migration and angiogenesis of human lung carcinoma cells.

Shaoxing Yang1, Fei Qi2, Chuanhao Tang1, Hong Wang1, Haifeng Qin1, Xiaoyan Li1, Jianjie Li1, Weixia Wang1, Changyun Zhao1, Hongjun Gao1.   

Abstract

Cluster of differentiation (CD) 147 is a transmembrane glycoprotein that is highly expressed at the tumor cell surface, which stimulates fibroblasts to produce a large number of matrix metalloproteinases and promotes tumor invasion and metastasis and tumor-induced angiogenesis. The present study investigated the functions and the role of CD147 in the human lung carcinoma A549 cell line. The present study constructed expression and interference [small interfering (si) RNA] lentiviral vectors of CD147, which established stable overexpression and low expression of CD147 in the A549 cell line, named A549-CD147 and A549-siCD147, respectively. The differences in biological features between various levels of CD147 expression in A549 cells was investigated by cell counting kit-8 (CCK-8), Transwell, scratch and lumen formation assays. The results of the CCK-8 assay revealed that A549-CD147 cell proliferation was significantly increased and A549-siCD147 cell proliferation was decreased compared with the control groups. The A549-CD147 cells had the largest number of cells penetrating the Matrigel in the Transwell assay, which indicates that upregulation of CD147 expression increases the infiltration capacity of cells. The scratch assay revealed that A549-CD147 cells have the highest capacity for migration, while A549-siCD147 cells have the lowest. Quantitative polymerase chain reaction and western blot analysis demonstrated that vascular endothelial growth factor (VEGF) expression was proportional to the expression level of CD147 at the mRNA and protein level. The lumen formation assay revealed that the number of vessel lumens that human umbilical vein endothelial cells formed in the A549-CD147 cell supernatant was increased compared with the A549-siCD147 cells. Collectively, the present results suggest that CD147 is important in the promotion of lung carcinoma cell proliferation, invasion and metastasis and the upregulation of VEGF, which stimulates the angiogenesis of lung carcinoma. In conclusion, CD147 may be a potential target in the treatment of lung carcinoma.

Entities:  

Keywords:  A549; CD147; lentiviral; malignant; tumor

Year:  2016        PMID: 28356976      PMCID: PMC5351401          DOI: 10.3892/ol.2016.5502

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  31 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression.

Authors:  Kazuki Nabeshima; Hiroshi Iwasaki; Kaori Koga; Hironobu Hojo; Junji Suzumiya; Masahiro Kikuchi
Journal:  Pathol Int       Date:  2006-07       Impact factor: 2.534

Review 3.  Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy.

Authors:  G Ranieri; G Gasparini
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2001-11

4.  A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma.

Authors:  Xiang Chen; Jing Lin; Takuro Kanekura; Juan Su; Wei Lin; Hongfu Xie; Yixi Wu; Juan Li; Mingliang Chen; Jing Chang
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

Review 5.  Pulmonary adenocarcinoma: a renewed entity in 2011.

Authors:  Humam Kadara; Mohamed Kabbout; Ignacio I Wistuba
Journal:  Respirology       Date:  2012-01       Impact factor: 6.424

6.  EMMPRIN silencing inhibits proliferation and perineural invasion of human salivary adenoid cystic carcinoma cells in vitro and in vivo.

Authors:  Xinjie Yang; Pu Zhang; Qin Ma; Liang Kong; Yuan Li; Baolin Liu; Delin Lei
Journal:  Cancer Biol Ther       Date:  2012-01-15       Impact factor: 4.742

7.  Bevacizumab-induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab.

Authors:  Jim Zhong; Arif N Ali; Alfredo D Voloschin; Yuan Liu; Walter J Curran; Ian R Crocker; Hui-Kuo G Shu
Journal:  Cancer       Date:  2014-12-29       Impact factor: 6.860

Review 8.  Lessons from phase III clinical trials on anti-VEGF therapy for cancer.

Authors:  Rakesh K Jain; Dan G Duda; Jeffrey W Clark; Jay S Loeffler
Journal:  Nat Clin Pract Oncol       Date:  2006-01

Review 9.  Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis.

Authors:  Masabumi Shibuya
Journal:  BMB Rep       Date:  2008-04-30       Impact factor: 4.778

10.  CD147 depletion down-regulates matrix metalloproteinase-11, vascular endothelial growth factor-A expression and the lymphatic metastasis potential of murine hepatocarcinoma Hca-F cells.

Authors:  Li Jia; Jun Cao; Wei Wei; Shujing Wang; Yunfei Zuo; Jianing Zhang
Journal:  Int J Biochem Cell Biol       Date:  2007-06-28       Impact factor: 5.085

View more
  7 in total

1.  Pseudolaric Acid B Inhibits Proliferation, Invasion, and Angiogenesis in Esophageal Squamous Cell Carcinoma Through Regulating CD147.

Authors:  Zhe Yin; Huarong Cai; Zhiqiang Wang; Yuequan Jiang
Journal:  Drug Des Devel Ther       Date:  2020-10-28       Impact factor: 4.162

2.  Non-invasive Prenatal Diagnosis of Chromosomal Aneuploidies and Microdeletion Syndrome Using Fetal Nucleated Red Blood Cells Isolated by Nanostructure Microchips.

Authors:  Chun Feng; Zhaobo He; Bo Cai; Jianhong Peng; Jieping Song; Xuechen Yu; Yue Sun; Jing Yuan; Xingzhong Zhao; Yuanzhen Zhang
Journal:  Theranostics       Date:  2018-02-02       Impact factor: 11.556

3.  CD147 Aggravated Inflammatory Bowel Disease by Triggering NF-κB-Mediated Pyroptosis.

Authors:  Zhaohui Xu; Ruitao Liu; Ling Huang; Yuxin Xu; Mingmin Su; Jiayu Chen; Lanlan Geng; Wanfu Xu; Sitang Gong
Journal:  Biomed Res Int       Date:  2020-06-30       Impact factor: 3.411

4.  Correlation between 18F-FDG maximum standardized uptake value with CD147 expression in lung adenocarcinomas: a retrospective study.

Authors:  Fei Guo; Xueyan Li; Guodong Yao; Guangchun Zeng; Lijuan Yu
Journal:  PeerJ       Date:  2019-09-09       Impact factor: 2.984

5.  CD147 Promotes Tumorigenesis via Exosome-Mediated Signaling in Rhabdomyosarcoma.

Authors:  Assil Fahs; Nader Hussein; Hasan Zalzali; Farah Ramadan; Farah Ghamloush; Hani Tamim; Mahmoud El Homsi; Bassam Badran; Fouad Boulos; Ayman Tawil; Sandra E Ghayad; Raya Saab
Journal:  Cells       Date:  2022-07-22       Impact factor: 7.666

6.  Discovery and validation of surface N-glycoproteins in MM cell lines and patient samples uncovers immunotherapy targets.

Authors:  Robyn A A Oldham; Mary L Faber; Theodore R Keppel; Amanda R Buchberger; Matthew Waas; Parameswaran Hari; Rebekah L Gundry; Jeffrey A Medin
Journal:  J Immunother Cancer       Date:  2020-08       Impact factor: 13.751

7.  Golgi α1,2-mannosidase I induces clustering and compartmentalization of CD147 during epithelial cell migration.

Authors:  Miguel Gonzalez-Andrades; Supriya S Jalimarada; Maria Rodriguez-Benavente; Marissa N Feeley; Ashley M Woodward; Dina B AbuSamra; Pablo Argüeso
Journal:  Cell Adh Migr       Date:  2020-12       Impact factor: 3.405

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.